IPIX Stock - Innovation Pharmaceuticals Inc.
Unlock GoAI Insights for IPIX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | $18,000 | N/A | $423,000 | N/A |
| Gross Profit | $-373,000 | $18,000 | $-378,000 | $423,000 | $-371,000 |
| Gross Margin | N/A | 100.0% | N/A | 100.0% | N/A |
| Operating Income | $-3,111,000 | $-6,921,000 | $-9,015,000 | $-4,635,000 | $-6,451,000 |
| Net Income | $-3,168,000 | $-7,041,000 | $-13,872,000 | $-6,648,000 | $-9,071,000 |
| Net Margin | N/A | -39116.7% | N/A | -1571.6% | N/A |
| EPS | $-0.01 | $-0.01 | $-0.04 | $-0.03 | $-0.05 |
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Visit WebsiteEarnings History & Surprises
IPIXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 6, 2024 | — | — | — | — |
Q4 2024 | Nov 19, 2024 | — | — | — | — |
Q3 2024 | Sep 27, 2024 | — | — | — | — |
Q2 2024 | May 29, 2024 | — | — | — | — |
Q1 2024 | Feb 12, 2024 | — | — | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 15, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 10, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 28, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 14, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 9, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 27, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 13, 2021 | — | $-0.01 | — | — |
Q1 2021 | Feb 22, 2021 | — | $-0.02 | — | — |
Q4 2020 | Nov 16, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 14, 2020 | — | $-0.01 | — | — |
Q2 2020 | May 14, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about IPIX
What is IPIX's current stock price?
What is the analyst price target for IPIX?
What sector is Innovation Pharmaceuticals Inc. in?
What is IPIX's market cap?
Does IPIX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IPIX for comparison